Pulling SEC filings + quote and writing the call…

FIRST BUSEY CORP /NV/
Next earnings Jul 28, 2026 · consensus $0.65 EPS, $202M rev
Last earnings +0.1% on 2026-04-28
Transformative merger doubled the balance sheet but diluted EPS and sank ROE to 5.5% — a ~3.6% yielder near book, fairly priced.
Diluted EPS $1.47 · FY2025
Middling fundamentals offset by an attractive price (~88% below fair value) — worth a look on the value angle.
First Busey just executed a transformative, stock-funded acquisition (the Leawood, KS office and Item 2 properties point to the CrossFirst combination): FY2025 total assets jumped +50.3% to $18.1B, revenue +55.7% to $720M, and stockholders' equity +78.5% to $2.47B. But the deal was paid for in shares — count rose +51.4% to 86.2M — so even though net income grew +19.0% to $135M, diluted EPS fell -25.8% to $1.47. The all-important bank metric, ROE, is just 5.5%, weak versus a ~10% cost of equity. That is the crux of the call: the franchise got bigger, not yet better, and the per-share economics went backwards.
Valuation is full for the current earning power. At $29.53 the P/E is 20.1x — rich for a regional bank — though the market cap of $2.55B sits barely above book equity of $2.47B (~1.0x book), and goodwill from the merger means tangible book is lower, so the price-to-tangible-book is meaningfully above 1x. The pre-merger record was flat: net income was $123M/$128M/$123M/$114M across FY2021–FY2024 on ~$450M revenue, so this is a steady-but-unexciting Midwest commercial bank, not a grower. The investment case rests entirely on management converting merger scale into cost synergies that lift ROE and re-grow EPS — plausible but unproven in these numbers.
Is BUSE a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | $450M | $442M | $462M | $720M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $123M | $128M | $123M | $114M | $135M |
| Diluted EPS | $2.20 | $2.29 | $2.18 | $1.98 | $1.47 |
| Net margin | — | 28.5% | 27.7% | 24.6% | 18.8% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting: director/officer changes and shareholder vote results disclosed
Q1 2026 10-Q: first clean post-merger quarter at ~$18B assets
Other-events filing, consistent with routine quarterly dividend declaration
Q1 2026 earnings release, first full post-CrossFirst quarter reported
Other-events filing, likely routine cash dividend declaration
2026 proxy: board slate, pay and auditor ratification put to shareholders
FY2025: rev +56%, NI +19%, but EPS -26% on merger dilution; IL tax suit filed
Other-events filing; routine corporate disclosure, no material change
Q4/FY2025 earnings: net income +19% to $135M on CrossFirst merger scale
Sources: SEC EDGAR (CIK 0000314489, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/30/2026, 3:55:22 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 11:55 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 3 sales
| 2026-06-15 | Cassens Michael David Director | Sell | 750.00 @ $28.92 | $21.7K |
| 2026-06-15 | Cassens Michael David Director | Sell | 5.53K @ $29.00 | $160K |
| 2026-05-15 | Cassens Michael David Director | Sell | 750.00 @ $26.11 | $19.6K |
| 2026-05-12 | BRADSHAW STANLEY J Director | Buy | 600.00 @ $25.99 | $15.6K |
| 2026-05-01 | Wehrli Scott A Director | Award | 125.00 | |
| 2026-05-01 | KENNEY FREDERIC L Director | Award | 303.00 | |
| 2026-05-01 | BRADSHAW STANLEY J Director | Award | 308.00 | |
| 2026-05-01 | RAUCKMAN KEVIN Director | Award | 62.00 | |
| 2026-05-01 | Grigsby Jennifer M Director | Award | 62.00 |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median